Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

February 2018

NEWSMAKER INTERVIEW: Ralph Taylor, CEO of Sysmex America

The Dark Report / By R. Lewis Dark

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures. Core laboratories have something unique and irreplaceable. Core laboratories will continue to anchor lab testing services in the communities they serve. What …

NEWSMAKER INTERVIEW: Ralph Taylor, CEO of Sysmex America Read More »

To access this post, you must purchase The Dark Report.

Health insurance fraud cases take new turn with HDL-BlueWave outcome

TDR Insider / By Mary Van Doren

This is an excerpt from a 2,700-word article in the February 12, 2018, issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: The outcome of the latest Medicare health insurance fraud trial …

Health insurance fraud cases take new turn with HDL-BlueWave outcome Read More »

To access this post, you must purchase The Dark Report.

Lab Executives Lose Big in Federal Jury Trial

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

RATHER THAN ENTER INTO A NEGOTIATED SETTLEMENT with federal prosecutors, the former executives of Health Diagnostic Laboratory (HDL) and BlueWave Healthcare Consultants decided to take their case to a jury in a federal court in South Carolina. The outcome has notable lessons for all lab managers and pathologists, as well as the attorneys who advise …

Lab Executives Lose Big in Federal Jury Trial Read More »

To access this post, you must purchase The Dark Report.

Insights from Jury Verdict in HDL, BlueWave Case

Laboratory Compliance / By Robert Michel

CEO SUMMARY: After a two-week trial, the executives of Health Diagnostic Laboratories and BlueWave Healthcare Consultants were found guilty of violating the federal False Claims Act. Defendants Tonya Mallory, Floyd Calhoun Dent III, and Robert Bradford Johnson were ordered to pay the United States millions for causing HDL to submit more than 35,000 false claims …

Insights from Jury Verdict in HDL, BlueWave Case Read More »

To access this post, you must purchase The Dark Report.

Use of ‘1099 Marketers’ and Lab Compliance Risk

Laboratory Compliance / By Jon Stone

CEO SUMMARY: Experts in lab compliance predict that clinical laboratories and anatomic pathology groups must anticipate tougher enforcement of federal and state laws this year. One source of increased compliance risk for lab companies is the rising use of third-party marketing agreements. David Gee, an experienced lab industry attorney at Davis Wright Tremaine, said lab …

Use of ‘1099 Marketers’ and Lab Compliance Risk Read More »

To access this post, you must purchase The Dark Report.

Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry

Laboratory Management / By Joseph Burns

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures.” —Ralph Taylor, President, Sysmex America, Inc. CEO Summary: To bring testing closer to patients, clinical laboratories will need to offer sophisticated …

Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry Read More »

To access this post, you must purchase The Dark Report.

GE Healthcare Sells Omnyx to Inspirata

Laboratory Management / By Joseph Burns

CEO SUMMARY: Now that the FDA has cleared a digital pathology for use in primary diagnosis, interest in DP is building. Inspirata purchased Omnyx and its assets because the Omnyx Dynamyx digital pathology software has strong features that could be integrated into Inspirata’s digital pathology solution. In this interview with THE DARK REPORT, Inspirata CEO …

GE Healthcare Sells Omnyx to Inspirata Read More »

To access this post, you must purchase The Dark Report.

Strategies to Offset Medicare Cuts to Be Shared at Exec. War College

Laboratory Billing / By Robert Michel

DEEP PRICE CUTS to the Medicare Part B Clinical Laboratory Fee Schedule was the big story of 2017. The big story of 2018 may be the widespread financial disruption to the clinical lab industry as labs see dramatic declines in their revenue from these Medicare fee cuts. One early opportunity for lab administrators and pathologists …

Strategies to Offset Medicare Cuts to Be Shared at Exec. War College Read More »

To access this post, you must purchase The Dark Report.

NILA: CLIA Proposal Doesn’t Address Flaws

Laboratory Compliance / By Joseph Burns

CEO SUMMARY: For many years, NILA has urged the federal Centers for Medicare and Medicaid Services to make significant changes in CLIA regulations. Yet, in its recent request for information, CMS addressed five specific areas. But the federal agency left out the need for a comprehensive overhaul of the CLIA regulations in other areas, including …

NILA: CLIA Proposal Doesn’t Address Flaws Read More »

To access this post, you must purchase The Dark Report.

February 12, 2018 Intelligence: Late Breaking Lab News

Late Breaking Lab News / By Robert Michel

Because of the explosion in different payment systems, hospitals, physicians, and providers such as clinical laboratories are facing a new challenge: how to match a payment to a specific patient’s service. Modern Healthcare writer Tara Bannow reports that, “back when most patients paid with cash or checks, most health systems relied solely on banks to handle …

February 12, 2018 Intelligence: Late Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

;